We previously reported that diabetes-mediated IL-17A enhanced ROS production in the retina, which was significantly decreased when the constitutively expressed IL-17 receptor was blocked in photoreceptor cells or when IL-17A was systemically ablated (Sigurdardottir et al., 2019). The gene discussed is IL17A; the disease is diabetes mellitus.